The ENCOMPASS Experience: Incorporating Bispecific Antibodies into the Care of Patients with Relapsed/Refractory Multiple Myeloma with an Emphasis on Managing Potential Adverse Events
Virtual Booth
Multidisciplinary care is an important aspect of the management of patients with multiple myeloma, providing care to manage disease-, treatment-, and patient-related complications. In addition to the involvement of hematology/oncology professionals, the broad reaching effects of multiple myeloma may require other specialty input.1 With a relatively high prevalence of renal disease in patients with multiple
Multidisciplinary Team Care Read More »
Although highly effective treatments are available in early-line settings of multiple myeloma management, such as proteasome inhibitors, immunomodulatory drugs (IMiDs), corticosteroids, and multiple drug combinations including anti-CD38 antibodies, treatment options for progressive disease following initial lines of therapy have historically been limited.1,2 Available therapies for the management of relapsed/refractory multiple myeloma include many of the
Evolving Therapeutics in Multiple Myeloma Read More »
The Association of VA Hematology/Oncology (AVAHO) is a non-profit organization dedicated to improving the lives of Veterans diagnosed with cancer and hematologic disorders. AVAHO’s current membership of nearly 1000 healthcare professionals is comprised of medical, surgical, and radiation oncologists, hematologists, pharmacists, mid-level providers, cancer registrars, social workers, and allied healthcare professionals from across the country.
Ding H, Xu J, Lin Z, et al. Minimal residual disease in multiple myeloma: Current status. Biomark Res. 2021;9(1):75. doi:10.1186/s40364-021-00328-2 National Comprehensive Cancer Network®. NCCN Clinical Practice Guidelines in Oncology. Multiple Myeloma. Version 5.2022. Published March 9, 2022. https://www.nccn.org/professionals/physician_gls/pdf/myeloma.pdf Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2022. CA Cancer J Clin. 2022;72(1):7-33.
TRAIN is a national learning network that provides thousands of high-quality training opportunities to more than two million professionals who protect and improve the public’s health. Powered by the Public Health Foundation (PHF), the TRAIN Learning Network brings together agencies and organizations in the public health, health care, and preparedness sectors to disseminate, track, and
Public Health Foundation Read More »